Ranked one of the best clinical decision support tools for health professionals worldwide, BMJ Best Practice provides step-by-step guidance on diagnosis, treatment and prevention.
Updated daily using robust evidence-based methodology and expert opinion, BMJ Best Practice provides you with access to the very latest clinical information.
US FDA approves ensifentrine for maintenance treatment
The US Food and Drug Administration (FDA) has approved ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults.
Human cases of bird flu associated with outbreak in poultry and dairy cattle in the US
Avian influenza A(H5N1) virus is currently causing a multistate outbreak in poultry and dairy cows in the US. While outbreaks have previously been reported in poultry, this is the first time the virus has been detected in cows. Cases of human infection linked to the outbreak in dairy cows have been reported, and these cases represent the first instances of likely mammal-to-human transmission globally.
NICE guidance recommends using NEWS2 to improve risk evaluation and management of sepsis in adults
Following a review of the evidence, the National Institute for Health and Care Excellence (NICE) in the UK has updated its guidance on management of sepsis in patients aged 16 years or over.
CDC updates advice for prevention and treatment of anthrax
The Centers for Disease Control and Prevention (CDC) has updated its 2014 recommendations for the post-exposure prophylaxis (PEP) and treatment of anthrax. The CDC based the updates on systematic reviews of studies involving in vitro antimicrobial drug activity against Bacillus anthracis, in vivo antimicrobial drug efficacy for PEP and treatment, in vivo and human anthrax antitoxin efficacy for PEP and treatment, and survival data.
The highest ranking* CDS app
Access clinical information anywhere, even offline, with our award-winning app.
Whether you’re on the ward, at home, or studying, the BMJ Best Practice app gives you trusted decision support information in an instant. The app is provided for free to those who have a personal subscription to BMJ Best Practice or have access provided by their institution.
* As of 23 August 2023
It’s no understatement to say that this app (and the website) is responsible for getting me through medical school. Nowhere else can you get such succinct and relevant summaries and treatment algorithms.
BMJ Best Practice app user
Introducing our new Frailty topic
Unlock essential insights into frailty with the latest addition to BMJ Best Practice
Recognising frailty is crucial. It’s an independent risk factor for adverse health outcomes, such as increased hospitalisations. By identifying frailty, we can tailor interventions to mitigate risks and improve outcomes. This topic is designed to equip you with the tools you need to navigate the complexities of frailty management, by helping you to:
- Identify frailty
- Navigate an ageing population
- Understand the implications of frailty
- Support the MDT
Have you used our Comorbidities Manager?
Managing the treatment of patients with comorbidities is hard – clinical guidelines only focus on single conditions – but failure to manage comorbidities leads to worse clinical outcomes and longer lengths of stay.
Our unique Comorbidities Manager* provides guidance on the treatment of a patient’s acute condition alongside their preexisting comorbidities.
*This feature is only available if your institution has purchased the Comorbidities Manager. If you have access it will appear under the ‘Your Profile’ section in the menu at the top of the page.
At a glance
One in three adults suffer from multiple chronic conditions and most patients in the acute setting have more than one medical condition.
- Treat patients with comorbidities with confidence
- Better understand the complexities of treating multiple conditions
- Achieve better outcomes for patients